Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
BioVectra
Pharma
Agilent will pay $925M to acquire specialty CDMO Biovectra
After changing hands several times throughout the 2010s, Canadian specialty CDMO Biovectra has agreed to fly the Agilent flag.
Fraiser Kansteiner
Jul 22, 2024 11:01am
Mallinckrodt unloads its CDMO for $250M as potential liabilities mount
Sep 10, 2019 10:34am
Mallinckrodt invests $100M in its BioVectra CDMO
Mar 6, 2019 12:36pm
